Funds and ETFs Anhui Anke Biotechnology (Group) Co., Ltd.

Equities

300009

CNE100000GY2

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
10.22 CNY +2.51% Intraday chart for Anhui Anke Biotechnology (Group) Co., Ltd. +2.92% -.--%

ETFs positioned on Anhui Anke Biotechnology (Group) Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 31 M€ +5.22% -
0.00% 34 M€ +2.67% -
Anhui Anke Biotechnology (Group) Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of biological products, Chinese patent drugs, chemical synthetic drugs, peptide drugs and nucleic acid detection products. The Company’s main products include recombinant human interferon alfa-2b series, recombinant human growth hormone, peptides Active Pharmaceutical Ingredients (APIs), customized peptides, deoxyribonucleic acid (DNA) fluorescence detection kit, silica beads extraction kit, anti-sperm antibody test kit, pain relieving ointment, amoxicillin granules and capsules, cefaclor dispersible tablets and adefovir dipivoxil tablets, among others. The Company distributes its products in domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.22 CNY
Average target price
19.54 CNY
Spread / Average Target
+91.19%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300009 Stock
  4. Funds and ETFs Anhui Anke Biotechnology (Group) Co., Ltd.